Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d5c76701a54362892d67c161dcaf7c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f53c382c05f5d15b0dbb9715ffa8d5a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
filingDate |
2004-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4acc696e2e46012488519d72e6becc83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76a646d80910b228011a399fef1d7213 |
publicationDate |
2004-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004099196-A1 |
titleOfInvention |
Benzoxazinone derivatives, their preparation and use |
abstract |
Compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed, wherein R1 is hydrogen or C1-6alkyl; and R2 is fluoro or chloro. Methods of preparation and uses thereof in treatment of CNS disorders, such as depression or anxiety, are also disclosed. |
priorityDate |
2003-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |